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ABSTRACT
The pedicled transverse rectus abdominis myocutaneous (TRAM) flap procedure is still widely used for breast reconstruction. The
repair of the flap harvest site in the transverse rectus abdominis muscle and sheath is often assisted by the use of prosthetic
meshes. This decreases the risk of abdominal wall weakness and herniation but, being a foreign body, it also carries the risk of
infection. In this report, we describe the case of a 63-year-old patient who, whilst receiving chemotherapy for metastatic breast
cancer, presented with an infected polytetrafluoroethylene mesh 15 years after pedicled TRAM flap immediate breast reconstruc-
tion. This necessitated mesh removal to treat the infection. Following a thorough review of the English literature, this is the longest
recorded presentation of an abdominal prosthetic mesh infection. The mechanism and aetiology of such a late complication are
discussed.
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Introduction
The pedicled transverse rectus abdominis myocutaneous
(TRAM) flap remains a well-recognised breast reconstruc-
tion method following mastectomy for the treatment of
breast cancer. Its advantages include complete autologous
reconstruction with durable long-term results while avoid-
ing the use of an implant and improving the abdominal
contour. However, it is associated with considerable donor
site morbidity and has the potential to develop an inci-
sional hernia following damage to the rectus sheath and
muscle during its harvest.1
Pedicled TRAM flap harvest often requires the reinforce-
ment of the rectus sheath with a synthetic mesh such as pol-
ypropylene (Marlex) or polytetrafluoroethylene (PTFE;
Gore-tex®) meshes or, more recently, biological meshes
such as the acellular dermal matrices to provide support and
prevent weakness of the anterior abdominal wall muscles at
this site.2,3 The use of a synthetic non-absorbable mesh pro-
vides a long-term solution with a lesser risk of degradation
and subsequent hernia recurrence However, as with any for-
eign body, meshes carry a risk of infection which often
require surgical removal [Falagas and Kasiakou 2005]. In
this case report, we present an unusually late PTFE mesh
infection, 15 years following its insertion to repair the
abdominal wall donor site at the time of a pedicled TRAM
flap breast reconstruction.
Case history
A 47-year-old woman underwent a right simple mastectomy,
axillary lymph node clearance and immediate reconstruc-
tion with an ipsilateral pedicled TRAM flap for right breast
carcinoma in October 2000. She required neoadjuvant che-
motherapy but no radiotherapy. The full thickness rectus
abdominis muscle and fascial defect was repaired with a
15 × 21 cm PTFE mesh (BARD Medical). On postoperative
day 5, she suffered partial flap necrosis loss, which necessi-
tated further reconstruction with a right latissimus dorsi flap
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eight weeks later, with no further early complications. She
remained disease free and asymptomatic from her abdomi-
nal incision until 2013 when she developed liver, bone and
renal metastases from her breast carcinoma. In March 2016,
15 years following her TRAM flap breast reconstruction, she
noted abdominal pain and swelling with purulent discharge
from her umbilicus but was systemically well. This dis-
charge was treated conservatively with dressings and intra-
venous antibiotics, as the collection was self-discharging
and she remained well. Her weekly chemotherapy (pacli-
taxel) continued.
In May 2016, while on the chemotherapy, the patient was
admitted with non-neutropenic sepsis with a suspected
intra-abdominal cause, because of the persistent umbilical
discharge. This discharge was treated with intravenous mer-
openem and vancomycin and the umbilical wound swabs on
admission grew sensitive Staphylococcus aureus. Following
admission, repeat abdominal computed tomography demon-
strated that the seroma had actually decreased in size but fat
stranding was noted around the collection (Figs 1 and 2).
There was no evidence of an intra-abdominal collection.
Following the trial of intravenous antibiotics, a multidisci-
plinary review recommended that the mesh be removed in
part or totally as indicated. The patient was then referred to
the plastic surgical service for further management. At
exploration via an extended periumbilical incision it was
found that there was seropurulent fluid (Fig 3) emanating
from a discharging sinus, which was also excised. Disinte-
grated PTFE mesh that had been sutured in place with Ethi-
bond (green suture) was identified in the sinus (Fig 4) and
extended to the groin. The mesh was totally removed,
together with the surrounding scar tissue (Fig 5).
After removal of the mesh, the transverse periumbilical
wound was dressed with a vacuum dressing and the wound
was closed directly six days later. Histology of the excised
sinus demonstrated no malignant metastases, indicating
only inflamed granulation tissue and surrounding fibrous
scarring with focal foreign body granulomatous reaction.
The patient was reviewed four weeks later with no further
infections and a well-healed scar.
Figure 1 Computed tomography of the abdomen 15+ years
after right (pedicled) TRAM flap harvest demonstrating a well-
demarcated right-sided anterior abdominal wall seroma
communicating with the umbilicus.
Figure 2 Computed tomography of the abdomen showing the
mesh within the right abdominal wall with surrounding fat
stranding.
Figure 3 Intraoperative image of the seropurulent fluid
emanating from a discharging sinus at the periumbilical
incision area (© Addenbrooke’s Hospital).
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Discussion
After a careful review of the literature in English, we believe
this to be the longest documented case of mesh infection,
occurring over 15 years after mesh insertion. Mesh infection
usually occurs due to local factors (pre-existing surgical-site
contamination, poor localised blood supply), patient or sys-
temic factors (immunosuppression, diabetes mellitus, smok-
ing status, malnutrition) or surgical factors (non-sterile
handling of the implant, lack of prophylactic antibiotics at
induction, emergency versus elective surgery). These infec-
tions occur soon after surgery, within weeks or months at
the latest. Infections presented many years after the abdomi-
nal wall mesh insertion are extremely uncommon.
One author (CMM) has previously reported such an infec-
tion in a 39-year-old woman who presented 6.5 years follow-
ing pedicled TRAM flap breast reconstruction. Similarly, a
PTFE (Gore-Tex®) mesh was used and the donor site was
closed in a similar fashion. The patient later presented with
abdominal pain and a urinary tract infection and subse-
quently developed recurrent lower abdominal sinuses,
which were excised in addition to removal of the PTFE
mesh. Removal of the mesh and antimicrobial treatment for
a proven Escherischia coli infection led to a complete resolu-
tion of symptoms in this particular case.
Delayed infections are unlikely to be related to any intrao-
perative factors, since these would have manifested at a
much earlier stage. Atypical causes should therefore be
explored. One of the mechanisms to be considered is the
haematogenous spread of an infection and late wound
breakdown, which would allow its introduction. Another
potential or possible cause is percutaneous drainage of a
reactive seroma, which may develop around a longstanding
foreign body. Percutaneous drainage could introduce skin
flora organisms into a deeper cavity where the mesh is
located. Thus, it is important to maintain strict aseptic tech-
nique, as well as minimising the number of attempts to drain
the fluid. Our patient did not undergo any percutaneous
drainage of their seroma.
The presence of a discharging periumbilical sinus in this
case is a possible cause, as a sinus can result in the mesh
communicating with the external environment. The pres-
ence of S. aureus supports an external infection through a
skin breach, as it is a common skin commensal which may
have spread into the tract and result in a deep infection.
However, the precedence of a periumbilical sinus is unlikely,
as the umbilical discharge and subsequent sinus formation
followed the occurrence of localised abdominal pain. A dis-
charging sinus may have gradually formed in the presence
of ongoing inflammation secondary to a seroma or collec-
tion. However, the immunosuppressive effect of some che-
motherapeutic agents used in the treatment of metastatic
breast cancer is the most likely predisposing factor account-
ing for the mesh infection in our patient. Immunosuppres-
sion can cause a transient bacteraemia and this can seed on
to a mesh anywhere in the body, resulting in a secondary
infection. An immunosuppressed patient such as ours is
likely to have developed a haematogenous infection of the
mesh leading to peri-implant seroma formation. The seroma
fluid subsequently followed the lowest resistance path, thus
discharging around the umbilicus.
Whatever the precipitating cause of the mesh infection, its
treatment involves complete removal, as we undertook with
our patient. Prosthetic mesh is a foreign body, stimulating a
localised tissue reaction and inflammatory response. Soft-
tissue infection in the presence of a foreign body (mesh), as
was demonstrated in this case, is usually difficult to treat
with antibiotics alone and is often impossible to eradicate.
This infection was therefore resolved only with removal of
the foreign material. Conroy et al. reported a similar case
with a 39-year-old patient reporting infection of a synthetic
Figure 4 Intraoperative image of the disintegrated PTFE mesh,
Ethibond sutures and scar tissue identified in the sinus and
extended to the groin (© Addenbrooke’s Hospital).
Figure 5 Intraoperative photograph of excised PTFE mesh
measuring 15 cm in length. The mesh was tightly adhered to
surrounding tissue within the described fluid collection.
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mesh 6.5 years following its insertion and resolved with
removal.4 However, that patient did not receive any chemo-
therapy, further supporting the theory that chemotherapy
played a role in allowing an opportunistic bacteraemia to
spread via a haematogenous route to the implant in an
immunocompromised patient.
The deep inferior epigastric flap, a rectus-muscle sparing
technique for breast reconstruction, has largely superseded
the practice of using a TRAM flap in our department. This in
turn has significantly reduced the need of a mesh for
abdominal wall reinforcement and thus the rate of weakness
when compared to TRAM flap reconstruction.
Long-term mesh infections are very uncommon. Chen et
al., for example, describe a series of eight patients, with a
late onset of mesh infection (range 3-60 months).5 Seven of
these patients had resolution of symptoms only when the
mesh was removed. Samee et al.6 reported a case of an
infected mesh seven years after a laparoscopic inguinal her-
nia repair and Foschi et al.7 report a similar case in a 48-
year-old with a three-year delay.
Conclusion
We believe that this is the longest delayed mesh infection
following any insertion of a synthetic implant in the current
literature. These late infections are extremely rare and usu-
ally associated with other factors such as immunosuppres-
sion or longstanding inflammatory responses. In the case of
a suspicion of deep infection, the current best treatment is
removal of the infected implant as it is unlikely to respond to
antimicrobial therapy alone.
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